The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery...
Date First Received: September 22, 2004
Last Updated: November 21, 2006
Verified by: Merck, September 2005
Clinical Trial Phase: Phase 3 | Start Date: May 2002
Overall Status: Completed
Estimated Enrollment: 450
Brief Summary
Official Title: “A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Single Dose Study of the Effect of Rofecoxib 50 mg and Valdecoxib 20 mg in Patients With Postoperative Dental Pain”
Condition Keyword(s):
Intervention(s):
The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Detailed Clinical Trial Description
The duration of treatment is 1 day.
Outcome Measures for this Clinical Trial
Primary:
- Overall analgesic effect over 12 hours.
Secondary:
- Overall analgesic effect over 8 hours.
- Time to onset of analgesic, peak analgesic and duration of analgesic effects.
- Overall analgesic, time to onset of analgesic, peak analgesic, and duration analgesic effects
- Safety and tolerability.
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Impaction of a molar tooth requiring removal
Exclusion Criteria:
- Known allergies to the study drug
Clinical Trials Locations, Contact Details, and Sponsors
Lead Sponsor: Merck
Related Publications
References
Daniels SE, Desjardins PJ, Bird SR, Smugar SS, Tershakovec AM. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies. Clin Ther. 2006 Jul;28(7):1022-34.
Additional Information
Information obtained from ClinicalTrials.gov on July 18, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00092300
Study ID Number: 2004_066
ClinicalTrials.gov Identifier: NCT00092300
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
